Daewoong Pharmaceutical Reports 34.2 Billion KRW Operating Profit in 3Q, Up 12.8% YoY
Daewoong Pharmaceutical announced on the 27th that its individual-based operating profit for the third quarter of this year was tentatively estimated at 34.197 billion KRW, an increase of 12.8% compared to the same period last year.
Hot Picks Today
"Could I Also Receive 370 Billion Won?"... No Limit on 'Stock Manipulation Whistleblower Rewards' Starting the 26th
- Samsung Electronics Labor-Management Reach Agreement, General Strike Postponed... "Deficit-Business Unit Allocation Deferred for One Year"
- "From a 70 Million Won Loss to a 350 Million Won Profit with Samsung and SK hynix"... 'Stock Jackpot' Grandfather Gains Attention
- "Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
![Daewoong Pharmaceutical Headquarters Building. [Photo by Daewoong Pharmaceutical]](http://www.asiae.co.kr/news/img_view.htm?img=2021032410060746368_1616547967.jpg)
Daewoong Pharmaceutical Headquarters Building. [Photo by Daewoong Pharmaceutical]
View original imageDuring the same period, sales recorded 303.026 billion KRW, growing by 0.52%. Net profit for the period decreased by 8.11% to 19.764 billion KRW.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
